Journal article
Genomic testing as a tool to optimise drug therapy
Australian Prescriber, Vol.40(3), pp.101-104
2017
Abstract
A person’s genetic make-up, including their ethnicity, can affect how they respond to a drug. It can also contribute to drug toxicity and efficacy.
Pharmacogenomic testing is now inexpensive, relatively fast and can enhance patient care.
Pre-emptive tests for azathioprine and abacavir are subsidised by Medicare.
A national regulatory system including standardised reporting and guidelines for interpreting test results is urgently needed. Improved education for GPs and pharmacists at postgraduate and undergraduate levels is also needed.
Details
- Title
- Genomic testing as a tool to optimise drug therapy
- Authors/Creators
- A.A. Somogyi (Author/Creator) - Royal Adelaide HospitalE. Phillips (Author/Creator) - Murdoch University
- Publication Details
- Australian Prescriber, Vol.40(3), pp.101-104
- Publisher
- NPS
- Identifiers
- 991005540263207891
- Copyright
- © 2016 NPS MedicineWise
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
104 File views/ downloads
43 Record Views